The shift from fee-for-service to Value-based Care (VBC) is increasing due to payer mandates and the long-term promise of improved outcomes and lower costs. However, this transformation is unfolding amid economic uncertainty, tariff-driven inflation, and healthcare provider financial strain. Several hospitals lack the capital, operational agility, or data integration required to scale VBC adoption effectively. As Centers for Medicare & Medicaid Services (CMS) expands its adoption through the Alternative Payment Model (APM) framework, healthcare providers struggle to align limited resources with long-term strategic goals. To succeed in this evolving environment, healthcare organizations must invest in automation, analytics, and AI-enabled tools that improve financial and clinical performance. Agentic AI offers the potential to ease documentation burdens, close care gaps, and support compliance in a fragmented data ecosystem. In this report, we highlight how the emerging divide in the VBC landscape, shaped by resource availability, risks exacerbating disparities in care quality and organizational resilience. The report offers actionable strategies to navigate payer demands, optimize contracts, and realign RCM provider partnerships to support value-based models. Scope Industry: healthcare Geography: North America Contents In this report, we: Simply the VBC concept Evaluate systemic barriers slowing VBC adoption Assess VBC adoption trends in the future Analyze the healthcare provider strategy blueprint for VBC’s success

As US healthcare providers grapple with a turbulent economic and regulatory landscape, new tariffs and evolving policies are reshaping operational and financial realities across the sector. In response, providers are reassessing spending, delaying technology investments, and seeking more cost-effective operations. This report explores how Revenue Cycle Management (RCM) providers can strategically help healthcare organizations navigate this disruption. It highlights key actions such as adopting flexible pricing, enhancing operational agility, and deploying targeted AI to improve efficiency and safeguard revenue. Designed for RCM leaders and healthcare stakeholders, the report offers practical guidance on turning disruption into opportunity by aligning solutions with shifting provider needs. Scope Industry: healthcare Geography: North America Contents This report covers the impact of tariffs and regulations on healthcare providers and outlines strategic and portfolio-specific actions RCM providers can take to mitigate risk, enhance value, and drive growth. Memberships Healthcare Payer and Provider Business Process Revenue Cycle Management Sourcing and Vendor Management

As the global MedTech industry adapts to the post-COVID-19 landscape, it faces a multitude of challenges including changing consumer preferences, staffing shortages, supply chain disruptions, and evolving regulatory frameworks. Additionally, there is increasing interest in advanced technologies such as generative AI, wearables, digital therapeutics, and medical robots, prompting providers to expand their digital portfolio. To meet these challenges and address evolving enterprise needs, MedTech providers are adopting a personalized approach and enhancing their offerings across the value chain. This includes investments in data-driven insights for manufacturing patient-friendly devices, advanced analytics for supply chain optimization, keeping up with regulations, and effective launch strategies in a competitive environment. Everest Group’s MedTech Operations – Service Provider Compendium 2024 provides comprehensive and fact-based snapshots of 15 MedTech operations service providers. Each provider profile offers a comprehensive picture of its company overview, key leaders, scale of operations, recent developments and investments, partnerships, technology solutions and capabilities, delivery locations, scope of services, and portfolio mix. The compendium will enable providers to benchmark themselves against their competitors, while buyers will be able to assess the providers based on the desired set of capabilities. Scope Industry: MedTech operations Geography: North America Contents In this report, we feature 15 MedTech operations service provider profiles and include: Service suite and scale of operations: key leaders, service suites, FTEs, revenue, recent developments, and partnerships Delivery locations: details of key delivery locations worldwide Capabilities and clients: major client engagements, revenue by process coverage, revenue by geography, revenue by buyer size, and revenue by delivery location Technology solutions and tools: brief descriptions of key MedTech operations technology solutions and tools Membership(s) Life Sciences Business Process Outsourcing Excellence

Over the past year, enterprises have faced significant macroeconomic and geopolitical challenges. The potential uncertainties surrounding the implementation of the Inflation Reduction Act (IRA), the escalation in federal interest rates aimed at curbing inflation, and the ongoing conflicts leading to the relocation of clinical trials from regions such as Russia and Ukraine, have prompted enterprises to reassess their strategies. Moreover, the introduction of generative AI technologies, such as ChatGPT, empowers biopharmaceutical and MedTech companies to revamp their offerings and deliver state-of-the-art technology and cost efficiencies. In response to enterprises’ evolving demands, providers are enhancing their capabilities across the life sciences operations value chain. They have directed investments into various avenues, including Decentralized Clinical Trials (DCT), with numerous IT / Business Process Outsourcing (BPO) firms forging partnerships with DCT providers. Furthermore, additional investments encompass analytics-driven tools for precision Healthcare Professional (HCP) profiling and targeting, as well as the adoption of automation tools in areas such as Adverse Events (AE) intake to swiftly adapt to market demands. In this report, we assess 28 life sciences operations service providers featured on the life sciences operations PEAK Matrix®. The study will enable life sciences enterprises to identify suitable providers to transform their business processes and differentiate themselves. Scope Industry: life sciences business process services Geography: global The assessment is based on Everest Group’s annual RFI process for the calendar year 2023, interactions with leading life sciences operations service providers, client reference checks, and an ongoing analysis of the life sciences operations market Contents In this report, we: Examine 28 life sciences operations service providers featured on the life sciences operations PEAK Matrix® Assess providers’ capabilities and market shares Membership(s) Life Sciences Business Process Outsourcing Excellence

The payment integrity market is dynamically transforming, continuously adapting and enhancing fundamental capabilities within the healthcare industry. The growing emphasis on ensuring accurate and efficient payment processes is creating various opportunities. Key trends gaining prominence include advances in fraud detection and prevention technologies, using sophisticated data analytics for claims validation, integrating AI to identify irregularities, and implementing predictive modeling to forecast potential risks. The industry is experiencing a surge in collaborations and partnerships among payment integrity solution providers, healthcare organizations, and regulatory bodies to create robust ecosystems that foster innovation. Additionally, there is a notable shift toward leveraging next-generation technologies, such as generative AI, to enhance payment accuracy. This evolution underscores the industry’s commitment to refining payment integrity practices through technology innovation and strategic collaborations. In this report, we analyze 18 payment integrity solutions providers featured on the Payment Integrity Solutions PEAK Matrix®. The report positions providers’ market shares relative to each other and evaluates their strengths and limitations. The study will enable healthcare payers to identify suitable providers to transform their business processes and differentiate themselves. Scope Industry: healthcare Geography: global The assessment is based on Everest Group’s annual RFI process for the calendar year 2023, interactions with leading payment integrity solutions providers, client references, and Everest Group’s ongoing analysis of the payment integrity solutions market Contents This report analyzes 18 payment integrity solutions providers and includes: Providers’ relative positioning on Everest Group’s PEAK Matrix® for Payment Integrity Solutions Providers’ capabilities and market shares Key strengths and limitations Membership(s) Healthcare Payer and Provider Business Process Sourcing and Vendor Management

Over the past one year, enterprises had to overcome a series of macroeconomic and geopolitical challenges. The potential uncertainties with the implementation of the Inflation Regulation Act (IRA), and the rise in federal interest rates to curb inflation, compounded by an ongoing war resulting in shifting of clinical trials from Russia and Ukraine, have forced enterprises to rethink their strategies. Further, the advent of generative AI such as ChatGPT will enable the biopharma and MedTech firms to repackage their offerings and provide cutting-edge technology and cost optimization. To effectively serve the evolving enterprise needs, service providers have invested in increasing the breadth and depth of their functionalities/offerings across the life sciences operations value chain. They have invested in a host of avenues such as Decentralized Clinical Trials (DCT), with many Information Technology / Business Process Outsourcing (IT/BPOs) companies partnering with DCT providers. Further investments include analytics-driven tools for razor-sharp Healthcare Professional (HCP) profiling and targeting, and the use of automation tools in areas such as Adverse Events (AE) intakes to rapidly evolve with the market needs. In this research, we present a detailed assessment of 28 operations service providers featured on the Life Sciences Operations Services PEAK Matrix®. We provide a relative positioning and analysis of the providers’ market shares, along with our evaluation of their strengths and limitations. This report will enable enterprises to identify suitable service providers to manage the evolving needs of their businesses. Scope Industry: life sciences BPS Geography: global The assessment is based on Everest Group’s annual RFI process for calendar year 2023, interactions with leading life sciences operations service providers, client reference checks, and an ongoing analysis of the life sciences operations market. Contents This report provides a detailed analysis of 28 operations service providers and includes: Relative positioning of the providers on Everest Group’s PEAK Matrix® for Life Sciences Operations Services Comparison of the providers’ capabilities and market shares Everest Group’s analysis of the providers’ strengths and limitations Membership(s) Life Sciences Business Process Sourcing and Vendor Management

Everest Group’s Life Sciences Sales and Marketing Operations – Service Provider Compendium 2023 provides comprehensive and fact-based snapshots of 17 life sciences sales and marketing service providers. It offers a detailed profile of each provider, with a comprehensive picture of its company overview, key leaders, scale of operations, recent developments and investments, partnerships, technology solutions and capabilities, talent initiatives, delivery locations, scope of services, and portfolio mix. Each profile also specifies the provider’s position on Everest Group’s PEAK Matrix® and offers an insightful analysis of its capabilities. The compendium will enable providers to benchmark themselves against their competitors, while buyers will be able to assess the providers based on the desired set of capabilities. Scope Industry: life sciences Geography: North America Contents In this research, we feature 17 life sciences sales and marketing operations service provider profiles and include: Service suite and scale of operations: key leaders, service suites, FTEs, revenue, recent developments, and partnerships Delivery locations: city-level detail of key delivery locations worldwide Capabilities and clients: major engagements, revenue by process coverage, revenue by geography, revenue by buyer size, and revenue by line of business Proprietary solutions and partnerships:brief descriptions of key life sciences sales and marketing technology solutions and partnerships Everest Group assessment:includes providers’ position on Everest Group’s PEAK Matrix®, along with their strengths and limitations Membership(s) Life Sciences Business Process Sourcing and Vendor Management

The life sciences industry is currently facing several challenges that are significantly impacting drug and device manufacturing costs. In addition to these rising costs, regulatory developments such as the Inflation Reduction Act 2023 and upcoming patent cliffs are further exacerbating the situation. As a result, it has become imperative for life sciences enterprises to establish robust sales and marketing operations to remain competitive. Additionally, the increasing involvement of end-consumers/patients in their healthcare decisions, coupled with evolving Healthcare Practitioner (HCP) needs, has compelled life sciences enterprises to explore the use of digital tools and technologies to enhance their market positioning and ensure continued engagement with their stakeholders. To effectively meet these evolving enterprise needs, providers are revamping their sales and marketing operations offerings. They are investing in a range of solutions, from point analytics such as HCP segmentation to large-scale multi-tower platform solutions covering marketing, promotion, and sales, along with investments in evolving technologies such as the metaverse for sales rep training. In this report, we assess 17 providers featured on Everest Group’s Life Sciences Sales and Marketing Operations – Services PEAK Matrix®. Each profile provides a comprehensive overview of the provider’s service focus, key Intellectual Property (IP) / solutions and domain investments. The study will enable buyers to choose the best-fit provider based on their sourcing considerations, while providers will be able to benchmark their performance against each other. Scope Industry: life sciences Geography: global The assessment is based on Everest Group’s annual RFI process for calendar year 2022, interactions with leading life sciences providers, client reference checks, and an ongoing analysis of the life sciences market Contents This report features 17 life sciences sales and marketing operations service provider profiles and includes: Providers’ position on Everest Group’s PEAK Matrix® for Life Sciences Sales and Marketing Operations Comparison of the providers’ capabilities and market shares Providers’ key strengths and limitations Membership(s) Life Sciences Business Process Sourcing and Vendor Management

Labeling and artwork are vital components of the life sciences industry, as they ensure regulatory compliance and can be used in packaging, online, and in the supply chain. Failure to comply with Good Manufacturing Practice (GMP) requirements, which include proofreading and change control, can lead to errors in labeling content, resulting in significant fines and drug recalls. In this viewpoint, we examine the evolving labeling and artwork landscape for the biopharmaceutical and medical device industries, current market trends, and the provider landscape, along with possible synergies. Industry Life Sciences BPS Geography Global Contents In this report, we examine: The evolving labeling and artwork landscape for biopharma and medical devices industries Current market trends The provider landscape and possible synergies Membership (s) Life Sciences Business Process Sourcing and Vendor Management

Life Sciences (LS) Operations – Service Provider Compendium provides accurate, comprehensive, and fact-based snapshots of 31 providers, including their scale of operations, technology solutions, and delivery locations, along with Everest Group’s PEAK Matrix® provider assessment. The compendium also sheds light on the global LS operations service provider landscape. The study will enable current and potential buyers of LS operations to assess the providers on their areas of strength and limitations based on desired capabilities. Scope Industry: life sciences Business Process Services (BPS) Geography: global Contents Each provider profile captures the following LS-related details: Services suite and scale of operations: key leaders, services suite, FTEs, revenue, recent developments, and partnerships Delivery locations: city-level detail of key delivery locations worldwide Capabilities and clients: major engagements, revenue split by geography and buyer size, and FTE split by process coverage and location Key technology solutions Everest Group assessment: provider’s position on the Everest Group PEAK Matrix®, market share and delivery capability assessment, and overall evaluation of capabilities Membership(s) Life Sciences Business Process Sourcing and Vendor Management